Real-World Data Back Avelumab in Merkel Cell Carcinoma
Avelumab demonstrates effectiveness against Merkel cell carcinoma in a real-world population, Medscape reports, extending evidence for the PD-L1 inhibitor beyond controlled trials.
Topic
Merkel Cell Carcinoma
Topic
Merkel Cell Carcinoma
Northwestern: Radiotherapy Reshapes Immune Response in Skin Cancer
Northwestern University researchers report that radiotherapy reprograms the immune response in a rare cutaneous malignancy. The i…
Snowboard Legend Faces Possible Total Vision Loss After 20-Year Rare Cancer Battle
A snowboarding legend's 20-year battle with a rare cancer now threatens total vision loss, People.com reports — a case underscori…